Abstract
1 min readEuroInterv.2007;3:149-153 Description Kaneka’s coronary stent, MAHOROBATM, is a new drug eluting stent (DES), which combines a thin, flexible cobalt-chromium (CoCr) metal stent platform coated with a biodegradable polymer including the pharmaceutical agent tacrolimus. The device has been designed and developed to inhibit the growth of neointimal hyperplasia and avoid interference with the vascular healing response.
Discussion(0)
No comments yet. Be the first to comment.